Biogen Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| IDP.F | AMGN | SNY | BMY | NVS | LLY | |
|---|---|---|---|---|---|---|
| Market cap | 31.63B | 241.57B | 99.21B | 127.49B | 297.65B | 1.16T |
| P/E (TTM) | 44.3 | 27.8 | 21.8 | 13.7 | 23.7 | 43.8 |
| Forward P/E | 10.4 | 18.3 | 7.8 | 9.4 | 16.0 | 27.7 |
| Price/book | 1.9 | 20.7 | 1.3 | 5.7 | 7.2 | 34.4 |
| Dividend yield | — | 2.30% | 5.90% | 4.12% | 3.08% | 0.54% |
| 1-year change | +71.39% | +49.66% | −17.27% | +39.45% | +16.93% | +54.77% |
| Today | −0.46% | +1.93% | +1.06% | +2.11% | +1.73% | +2.75% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All IDP.F news ›Biogen Q3 Earnings Preview: Grounds For Optimism, But Disappointment The Norm
Seeking Alpha - Biogen is rated Hold ahead of Q3 2026 earnings, with cautious optimism due to pipeline catalysts and improving growth portfolio performance. - MS franchise and Alzheimer's therapies face patent expiries, competition, and…
TD Cowen Adjusts Price Target on Biogen to $250 From $225
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for ... TD Cowen Adjusts Price Target on Biogen…
TD Cowen maintains Buy rating on Biogen, $250 price target
TD Cowen maintained their Buy rating on Biogen's stock with a price target of $250.00. The price target implies an upside of 2.8% from the Oct 20 close of $243.10. Strong Growth from New Products: Biogen's newer therapies, such as Leqembi…
Blood-Based Alzheimer's Tests Market Is Going to Boom |• C2N Diagnostics • Quest Diagnostics • Biogen
openPR.com Blood-Based Alzheimer's Tests Market Is Going to Boom |• C2N Diagnostics • Quest Diagnostics • Biogen Press release from: Coherent Market Insights Permanent link to this press release: You can edit or delete your press release…
Biogen rises as investors react to fresh kidney-disease data and pipeline optimism
$BIIB insiders have traded $BIIB stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales. We have seen 520 institutional investors add shares of $BIIB stock to their portfolio,…
Wells Fargo Adjusts Price Target on Biogen to $310 From $250
marketscreener.com Wells Fargo Adjusts Price Target on Biogen to $310 From $250 Published on 10/20/2026 at 06:43 am EDT
Wedbush Trims Price Target on Biogen to $212 From $215, Keeps Neutral Rating
Biogen has an average rating of overweight and mean price target of $243.86, according to analysts polled by FactSet. ... Wedbush Trims Price Target on Biogen to $212 From $215, Keeps Neutral Rating Published on 10/19/2026 at 07:18 am EDT
Stoke Therapeutics and Biogen Present Long-Term Clinical Data Supporting Disease-Modifying Potential of Zorevunersen for Dravet Syndrome
Published on 09/03/2026 at 11:35 pm EDT A new exploratory sub-analysis also showed substantial reductions in the most severe seizure types, which are the leading risk factor for sudden unexpected death in epilepsy (SUDEP). An additional…
Biogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Week
Red Cat Announces Proposed Voluntary Public Purchase Offer for Steyr Motors Evaxion reports sustained clinical responses for all patients at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01 Transocean Ltd.…
Biogen expands its Springbok range with a Protein Flapjack and Cognizin-infused shot
Biogen expands its Springbok range with oat-based Protein Flapjacks, 200mg caffeine Game Day Boost shots, and branded shakers and bottles. Check out Stack3d's most popular stories before you go Biogen expands its Springbok range with a…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com17
-
gurufocus.com3
-
kalkinemedia.com3
-
openpr.com3
-
seekingalpha.com3
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 68 articles, not a forecast.